188 related articles for article (PubMed ID: 24010934)
21. CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
Buolamwini JK; Assefa H
J Med Chem; 2002 Feb; 45(4):841-52. PubMed ID: 11831895
[TBL] [Abstract][Full Text] [Related]
22. 3D-QSAR analysis of a new type of acetylcholinesterase inhibitors.
Liu A; Guang H; Zhu L; Du G; Lee SM; Wang Y
Sci China C Life Sci; 2007 Dec; 50(6):726-30. PubMed ID: 17914643
[TBL] [Abstract][Full Text] [Related]
23. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods.
Zhu YQ; Lei M; Lu AJ; Zhao X; Yin XJ; Gao QZ
Eur J Med Chem; 2009 Apr; 44(4):1486-99. PubMed ID: 18771818
[TBL] [Abstract][Full Text] [Related]
24. QSAR analyses on avian influenza virus neuraminidase inhibitors using CoMFA, CoMSIA, and HQSAR.
Zheng M; Yu K; Liu H; Luo X; Chen K; Zhu W; Jiang H
J Comput Aided Mol Des; 2006 Sep; 20(9):549-66. PubMed ID: 17103017
[TBL] [Abstract][Full Text] [Related]
25. 3D-QSAR analysis of MCD inhibitors by CoMFA and CoMSIA.
Pourbasheer E; Aalizadeh R; Ebadi A; Ganjali MR
Comb Chem High Throughput Screen; 2015; 18(8):751-66. PubMed ID: 26234508
[TBL] [Abstract][Full Text] [Related]
26. Computational Analysis of CRTh2 receptor antagonist: A Ligand-based CoMFA and CoMSIA approach.
Babu S; Sohn H; Madhavan T
Comput Biol Chem; 2015 Jun; 56():109-21. PubMed ID: 25935115
[TBL] [Abstract][Full Text] [Related]
27. 3D-QSAR analysis of human immunodeficiency virus entry-1 inhibitors by CoMFA and CoMSIA.
Pirhadi S; Ghasemi JB
Eur J Med Chem; 2010 Nov; 45(11):4897-903. PubMed ID: 20810190
[TBL] [Abstract][Full Text] [Related]
28. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.
Zhou A; Hu J; Wang L; Zhong G; Pan J; Wu Z; Hui A
J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408
[TBL] [Abstract][Full Text] [Related]
29. 3D QSAR studies on T-type calcium channel blockers using CoMFA and CoMSIA.
Doddareddy MR; Jung HK; Cha JH; Cho YS; Koh HY; Chang MH; Pae AN
Bioorg Med Chem; 2004 Apr; 12(7):1613-21. PubMed ID: 15028254
[TBL] [Abstract][Full Text] [Related]
30. Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of thiazolone derivatives as hepatitis C virus NS5B polymerase allosteric inhibitors.
Lei B; Du J; Li S; Liu H; Ren Y; Yao X
J Comput Aided Mol Des; 2008 Oct; 22(10):711-25. PubMed ID: 18716715
[TBL] [Abstract][Full Text] [Related]
31. CoMFA and CoMSIA 3D-QSAR analysis of diaryloxy-methano-phenanthrene derivatives as anti-tubercular agents.
Shagufta ; Kumar A; Panda G; Siddiqi MI
J Mol Model; 2007 Jan; 13(1):99-109. PubMed ID: 16858589
[TBL] [Abstract][Full Text] [Related]
32. A systematic quantitative approach to rational drug design and discovery of novel human carbonic anhydrase IX inhibitors.
Sethi KK; Verma SM
J Enzyme Inhib Med Chem; 2014 Aug; 29(4):571-81. PubMed ID: 24090419
[TBL] [Abstract][Full Text] [Related]
33. Two- and three-dimensional quantitative structure-activity relationships for a series of purine nucleoside phosphorylase inhibitors.
Castilho MS; Postigo MP; de Paula CB; Montanari CA; Oliva G; Andricopulo AD
Bioorg Med Chem; 2006 Jan; 14(2):516-27. PubMed ID: 16203153
[TBL] [Abstract][Full Text] [Related]
34. Docking-based CoMFA and CoMSIA studies on naphthyl-substituted diarylpyrimidines as NNRTIs.
Wu HQ; Yao J; He QQ; Chen FE
SAR QSAR Environ Res; 2014; 25(10):761-75. PubMed ID: 25242254
[TBL] [Abstract][Full Text] [Related]
35. 3D-QSAR and molecular docking study of LRRK2 kinase inhibitors by CoMFA and CoMSIA methods.
Pourbasheer E; Aalizadeh R
SAR QSAR Environ Res; 2016 May; 27(5):385-407. PubMed ID: 27228480
[TBL] [Abstract][Full Text] [Related]
36. Hologram QSAR models of 4-[(diethylamino)methyl]-phenol inhibitors of acetyl/butyrylcholinesterase enzymes as potential anti-Alzheimer agents.
de Souza SD; de Souza AM; de Sousa AC; Sodero AC; Cabral LM; Albuquerque MG; Castro HC; Rodrigues CR
Molecules; 2012 Aug; 17(8):9529-39. PubMed ID: 22878227
[TBL] [Abstract][Full Text] [Related]
37. Insight into the structural requirements of narlaprevir-type inhibitors of NS3/NS4A protease based on HQSAR and molecular field analyses.
Zhu J; Li Y; Yu H; Zhang L; Mao X; Hou T
Comb Chem High Throughput Screen; 2012 Jul; 15(6):439-50. PubMed ID: 22263860
[TBL] [Abstract][Full Text] [Related]
38. Exploring molecular structural requirement for AChE inhibition through multi-chemometric and dynamics simulation analyses.
Hossain T; Saha A; Mukherjee A
J Biomol Struct Dyn; 2018 Apr; 36(5):1274-1285. PubMed ID: 28417668
[TBL] [Abstract][Full Text] [Related]
39. QSAR studies on benzothiophene derivatives as Plasmodium falciparum N-myristoyltransferase inhibitors: Molecular insights into affinity and selectivity.
Garcia ML; de Oliveira AA; Bueno RV; Nogueira VHR; de Souza GE; Guido RVC
Drug Dev Res; 2022 Apr; 83(2):264-284. PubMed ID: 32045013
[TBL] [Abstract][Full Text] [Related]
40. Pharmacophore-based 3D-QSAR of HIF-1 inhibitors.
Chung JY; Pasha FA; Cho SJ; Won M; Lee JJ; Lee K
Arch Pharm Res; 2009 Mar; 32(3):317-23. PubMed ID: 19387572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
